CANbridge Pharmaceuticals Ltd Listed on Main Board of Hong Kong Stock Exchange
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc. (“Canbridge” or the “company,” stock code 1228.HK), a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development, and commercialization of […]